Search company, investor...

GlidePath

glidepathgroup.com

Founded Year

1972

Stage

Acquired | Acquired

About GlidePath

Glidepath designs, integrates, installs and commissions automated solutions for airport baggage handling systems and self-service bag drops. On November 13, 2019, GlidePath was acquired by B2A Technology, terms of the agreement were not disclosed.

Headquarters Location

17-19 Patiki Rd

Auckland, 1026,

New Zealand

+64 9 818 3354

Missing: GlidePath's Product Demo & Case Studies

Promote your product offering to tech buyers.

Reach 1000s of buyers who use CB Insights to identify vendors, demo products, and make purchasing decisions.

Missing: GlidePath's Product & Differentiators

Don’t let your products get skipped. Buyers use our vendor rankings to shortlist companies and drive requests for proposals (RFPs).

GlidePath Patents

GlidePath has filed 1 patent.

patents chart

Application Date

Grant Date

Title

Related Topics

Status

2/23/2011

3/18/2014

Tires, Tire manufacturers, Packaging machinery, Vehicle technology, Bulk material handling

Grant

Application Date

2/23/2011

Grant Date

3/18/2014

Title

Related Topics

Tires, Tire manufacturers, Packaging machinery, Vehicle technology, Bulk material handling

Status

Grant

Latest GlidePath News

Navigating the New FMAP Glidepath FMAP Changes in the Consolidated Appropriations Act of 2023

Jan 6, 2023

To embed, copy and paste the code into your website or blog: <iframe frameborder="1" height="620" scrolling="auto" src="//www.jdsupra.com/post/contentViewerEmbed.aspx?fid=b1617b4f-491a-4681-bdca-ede02a547f22" style="border: 2px solid #ccc; overflow-x:hidden !important; overflow:hidden;" width="100%"></iframe> In response to the COVID-19 pandemic and the expected economic downturn, Section 6008 of the Families First Coronavirus Response Act of 2020 (Families First) established a temporary 6.2% increase in the Medicaid federal medical assistance percentage (FMAP), effective January 1, 2020, to last through the last day of the calendar quarter in which the COVID-19 public health emergency (PHE) ended. One condition of the FMAP increase was a prohibition on Medicaid disenrollment during the PHE. L. 117-328) – enacted over the holidays – makes several notable changes to the FMAP increase and related Medicaid eligibility redetermination and disenrollment requirements. Although these FMAP changes are obviously important to States, they are also important to providers and local government entities that may be funding the non-federal share of Medicaid payments through intergovernmental transfers or provider taxes. FMAP Increase Transition Period Section 5131 of Division FF of the Consolidated Appropriations Act of 2023 establishes a “transition period” for the Families First FMAP increase: Time period 6.2 percent 5 percent 2.5 percent 1.5 percent New Conditions Section 5131 also imposes new conditions on States’ receipt of the enhanced FMAP during the transition period beginning April 1, 2023. In particular: Eligibility Redeterminations.— A State that fails to meet any of the following conditions will not qualify for the FMAP increase for the applicable calendar quarter: Eligibility redeterminations must be in accordance with all Federal requirements. The State must attempt to ensure up-to-date contact information (including a mailing address, phone number, and email address) for each eligibility redetermination using the National Change of Address Database Maintained by the United States Postal Service, State health and human services agencies, or other reliable sources of contact information. The State may not disenroll any individual based on returned mail unless the State first undertakes a good faith effort to contact the individual using more than one modality. Note that these requirements do not prohibit a State from initiating renewals, post-enrollment verifications, and redeterminations over a 12-month period for all individuals who are enrolled in the State’s Medicaid program as of April 1, 2023. Reporting Requirements.—The FMAP for a State that does not satisfy new reporting requirements will be reduced by 0.25 percentage points times the number of fiscal quarters for which the State has failed to satisfy such requirements, although the reduction can be no greater than 1 percentage point. Specifically, beginning April 1, 2023 and lasting through June 30, 2024, each State will be required to submit monthly reports to the Department of Health and Human Services (HHS) on the State’s activities relating to eligibility redeterminations, including, but not limited to, the number of eligibility renewals initiated and the number of individuals whose Medicaid coverage was terminated. These reports will be publicly available. In addition, if HHS determines that a State did not comply with eligibility redetermination and reporting requirements during the April 1, 2023 to June 30, 2024 period, HHS may, in addition to other remedies, require that the State submit and implement a corrective action plan. If a State fails to submit or implement an approved corrective action plan, HHS may require the State suspend making all or some eligibility terminations and may impose civil money penalties of up to $100,000 per day.

GlidePath Frequently Asked Questions (FAQ)

  • When was GlidePath founded?

    GlidePath was founded in 1972.

  • Where is GlidePath's headquarters?

    GlidePath's headquarters is located at 17-19 Patiki Rd, Auckland.

  • What is GlidePath's latest funding round?

    GlidePath's latest funding round is Acquired.

  • Who are the investors of GlidePath?

    Investors of GlidePath include B2A Technology.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.